Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,196 | 23,289 | 9,565 | 19,866 | 35,704 |
| TOTAL | $14,039 | $24,250 | $10,453 | $20,530 | $36,572 |
| Non-Current Assets | |||||
| PPE Net | 549 | 757 | 1,090 | 419 | 345 |
| Other Non-Current Assets | 391 | 467 | 532 | 642 | 286 |
| TOTAL | $940 | $1,224 | $1,622 | $1,060 | $630 |
| Total Assets | $14,978 | $25,474 | $12,076 | $21,590 | $37,202 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,424 | 7,585 | 9,179 | 5,478 | 3,855 |
| Other current liabilities | 226 | 1,718 | 16,121 | 5,972 | N/A |
| TOTAL | $4,750 | $9,388 | $25,359 | $11,502 | $3,990 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,691 | 1,792 | 1,876 | 1,935 | 166 |
| TOTAL | $1,691 | $1,792 | $1,876 | $1,935 | $166 |
| Total Liabilities | $6,441 | $11,179 | $27,235 | $13,437 | $4,157 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,240 | 1,534 | 1,074 | 324 | 203 |
| Retained earnings | -269,134 | -247,343 | -202,761 | -159,990 | -150,898 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 1,382 |
| TOTAL | $8,537 | $14,295 | $-15,159 | $8,153 | $33,045 |
| Total Liabilities And Equity | $14,978 | $25,474 | $12,076 | $21,590 | $37,202 |